← Ricerca.Paziente.info
Browse research by treatment
1,000 treatments and interventions are being studied right now — from new medicines to therapies, devices and lifestyle programmes.
- Placebo6641210
- Pembrolizumab106212
- Carboplatin68139
- Cisplatin55118
- Paclitaxel42106
- Desametasone4890
- Ciclofosfamide3783
- Durvalumab3281
- Gemcitabine3976
- Bevacizumab4576
- Nivolumab3273
- Docetaxel3572
- Atezolizumab2468
- Rituximab2767
- Pemetrexed3067
- Lenalidomide1858
- No intervention4858
- Oxaliplatin2852
- Capecitabine2651
- Doxorubicin2346
- Prednisone1944
- Standard of Care2744
- Daratumumab2241
- risonanza magnetica (MRI)3340
- Questionnaires3439
- Nab-paclitaxel1838
- campione di sangue3038
- Pomalidomide1937
- Venetoclax2137
- Fludarabine1536
- Olaparib1134
- Bortezomib1334
- fulvestrant1533
- Enzalutamide1532
- Magnetic Resonance Imaging1832
- Irinotecan2032
- Cetuximab2031
- Tocilizumab1731
- Radioterapia1431
- Etoposide1531
- Obinutuzumab1230
- Leucovorin1930
- Biospecimen Collection1430
- Abemaciclib928
- Vincristine1228
- Letrozole1328
- Questionnaire2628
- Temozolomide1327
- Trastuzumab1327
- Blood sampling2426
- Trastuzumab deruxtecan1525
- Radiation therapy825
- Palbociclib624
- Ribociclib1324
- Everolimus1224
- Control1624
- Esercizio1724
- Fluorouracil1223
- Semaglutide923
- Usual care1623
- Acalabrutinib922
- Cabozantinib821
- Epcoritamab421
- Ruxolitinib921
- Dostarlimab821
- Rilvegostomig1721
- Sacituzumab tirumotecan1521
- Carfilzomib920
- Azacitidine1120
- Tirzepatide1319
- Cemiplimab919
- Data collection1519
- Ipilimumab919
- Teclistamab719
- Computed Tomography719
- Inavolisib1018
- Pumitamig1818
- Bendamustine918
- Upadacitinib618
- Exemestane718
- This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.918
- Laboratory Biomarker Analysis218
- Lenvatinib518
- Amivantamab818
- Quality-of-Life Assessment618
- 5-Fluorouracil1418
- Questionnaire Administration818
- Risankizumab818
- Cytarabine818
- Osimertinib317
- Guselkumab717
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.717
- Dupilumab517
- Methotrexate817
- Chemioterapia916
- Zanubrutinib616
- Niraparib616
- KEYTRUDA 25 mg/mL concentrate for solution for infusion1016
- Topotecan916
- Anastrozole516
- Prednisolone1216
- Tremelimumab516
- Midazolam1016
- observation1216
- Belzutifan715
- trametinib615
- Tamoxifen515
- Avelumab415
- Methylprednisolone614
- Sunitinib714
- Metformina814
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.414
- Abiraterone Acetate414
- Elranatamab1114
- Rescue medication1414
- Blood samples1214
- Pirtobrutinib713
- Glofitamab613
- Talquetamab613
- IMFINZI 50 mg/mL concentrate for solution for infusion.713
- Baricitinib1013
- Ibrutinib513
- Vinorelbine613
- Abiraterone712
- Mirikizumab812
- Ocrelizumab212
- Deucravacitinib512
- Belantamab mafodotin512
- Nipocalimab912
- Matching placebo712
- Apalutamide412
- Bimekizumab812
- JNJ-77242113112
- control group1012
- Giredestrant512
- Sonrotoclax711
- IMVT-1402811
- Capivasertib311
- Darolutamide711
- Ustekinumab311
- Volrustomig611
- Biopsia911
- Esame del sangue1111
- Entrectinib310
- Iberdomide510
- Dacarbazine410
- Orforglipron510
- Pertuzumab410
- Dato-DXd410
- Adalimumab310
- Selinexor110
- Tacrolimus610
- Empagliflozin610
- FOLFOX910
- Isatuximab710
- enfortumab vedotin310
- Sotorasib610
- No Intervention: Observational Cohort1010
- Chirurgia610
- Osservazionale810
- standard care610
- Afimkibart69
- Adagrasib79
- Filgotinib59
- Panitumumab89
- Irradiazione59
- Aspirina59
- Apixaban49
- Eribulin39
- KarXT99
- Ifosfamide59
- Cagrilintide39
- sample collection99
- SBRT49
- Anakinra89
- Psilocybin69
- Saline69
- Tezepelumab49
- Tucatinib39
- Virtual Reality79
- IPTACOPAN59
- Alectinib39
- efgartigimod PH20 SC49
- Normal Saline79
- Placebo oral tablet59
- Polatuzumab vedotin39
- Retatrutide29
- Linvoseltamab88
- Encorafenib48
- Alpelisib38
- Rivaroxaban58
- Odronextamab68
- Tislelizumab68
- Blinatumomab78
- Dasatinib48
- Dapagliflozin48
- Rescue Medications58
- Surovatamig88
- Zanidatamab68
- Inclisiran48
- Tarlatamab28
- prednisone/prednisolone78
- Divarasib58
- Ianalumab28
- Pulmonary vein isolation78
- Mitapivat28
- Standard of Care (SOC)68
- Biopsy Procedure28
- Not applicable (observational study)88
- Placebo Administration38
- Ramucirumab38
- Calderasib77
- LHRH Agonist17
- Zimberelimab7
- Elotuzumab37
- Binimetinib57
- Etentamig57
- Sonelokimab37
- NNC0487-011167
- Corticosteroidi37
- Questionnaire and Physical Exam77
- Camizestrant47
- Temozolomide (TMZ)57
- Deucrictibant67
- Datopotamab Deruxtecan27
- Lazertinib27
- ADT27
- Bariatric Surgery67
- Patritumab deruxtecan67
- Rilzabrutinib57
- Blood sample collection77
- Depemokimab47
- Folinic acid47
- Risonanza magnetica57
- teriflunomide17
- Belimumab67
- Placebo Control67
- transcranial direct current stimulation77
- Trifluridine-Tipiracil47
- Tulisokibart47
- Benralizumab37
- Biological collection77
- Brenipatide77
- Dieta77
- Puntura lombare67
- PET-MRI67
- Platinum based chemotherapy37
- Sacituzumab govitecan67
- Sham (No Treatment)77
- Sparsentan57
- Cognitive assessment67
- Ecocardiogramma77
- Luspatercept37
- Positron Emission Tomography47
- secukinumab17
- Stereotactic ablative radiotherapy37
- The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.57
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.17
- Tiragolumab27
- Saruparib67
- Brentuximab vedotin36
- FOLFIRI66
- Elecoglipron66
- Breath test56
- Nemolizumab46
- Ipatasertib26
- OPDIVO 10 mg/mL concentrate for solution for infusion.46
- APG77736
- Crizotinib26
- Sacituzumab Govitecan-hziy16
- Domvanalimab6
- XBD17366
- levoleucovorin36
- AZD139036
- Mosunetuzumab46
- Zanzalintinib56
- 5-FU16
- Atogepant46
- Azacitidine (AZA)56
- Remibrutinib26
- INZ-70126
- Not provided at time of registration6
- Momelotinib56
- Pegcetacoplan36
- Lunsekimig46
- Nerandomilast46
- Intensity-Modulated Radiation Therapy26
- INDOCYANINE GREEN56
- AZD012066
- Frexalimab36
- Gemcitabine + cisplatin16
- 5-fluorouracil (5-FU)66
- Maridebart Cafraglutide36
- Sham46
- Exercise training66
- Risdiplam36
- Amoxicillin36
- Dexmedetomidine66
- Inulina66
- Ceralasertib26
- Routine care66
- Tecentriq 1 200 mg concentrate for solution for infusion56
- Zongertinib56
- Pembrolizumab (KEYTRUDA®)46
- Placebo IV46
- Protein Supplement56
- Telisotuzumab adizutecan46
- Trastuzumab Emtansine16
- Vinblastine46
- Zilovertamab vedotin46
- Anifrolumab56
- Cardiac MRI46
- Cetrelimab16
- Lebrikizumab36
- Lutikizumab16
- Non-Interventional Study56
- PREHABILITATION56
- Sham Procedure26
- Stereotactic body radiotherapy36
- Survodutide46
- Time restricted eating66
- Tranexamic Acid56
- Vedolizumab56
- Venepuncture46
- Whey protein56
- Amlitelimab6
- Bone Scan56
- Busulfan46
- Ezabenlimab16
- Ketamine Hydrochloride46
- Neuropsychological tests56
- Non-interventional46
- Observational study66
- Pemetrexed/Carboplatin16
- Sotatercept26
- Standard treatment56
- riliprubart66
- Itraconazole45
- Imatinib45
- Golcadomide25
- Androgen Deprivation Therapy (ADT)35
- Placebo Comparator45
- Vemurafenib25
- AZD98335
- Nivolumab + Relatlimab45
- Ravulizumab25
- Rosuvastatina45
- Inebilizumab45
- Furmonertinib5
- Revumenib35
- Intismeran autogene25
- Relatlimab35
- SGM-10155
- Elritercept55
- Placebo (matched to NNC0487-0111)45
- Lecanemab15
- Supportive care measures35
- Obexelimab15
- Selumetinib15
- Capmatinib35
- Cobimetinib15
- Stereotactic Body Radiation Therapy15
- Ecografia35
- Emicizumab35
- Hydrocortisone35
- Oleclumab15
- Norepinephrine55
- Mavacamten25
- Opevesostat45
- KarX-EC55
- ASTX72735
- Axitinib5
- Mycophenolate Mofetil55
- Vicadrostat45
- AFLIBERCEPT45
- Elacestrant35
- Felzartamab35
- Route of administration: oral use45
- Colchicine45
- 177Lu-PSMA-61725
- Botulinum toxin type A15
- Photobiomodulation55
- Tebentafusp45
- Transthoracic Echocardiogram45
- Cefazolin45
- Daraxonrasib55
- Mepolizumab15
- Fisioterapia45
- Radiofrequency ablation45
- Aerobic Exercise45
- Brachytherapy25
- Ablazione con catetere35
- Dietary Intervention35
- Risonanza magnetica (MRI)55
- Mitomycin C35
- Regorafenib25
- Transcranial Magnetic Stimulation45
- Vincristine Sulfate5
- Vehicle Cream45
- Active Surveillance35
- barzolvolimab35
- BCG35
- Exercise Intervention45
- Futibatinib35
- Ifinatamab deruxtecan45
- Biopsia epatica45
- Intervento Coronarico Percutaneo45
- Placebo tablet35
- Quality of Life questionnaires35
- Standard Care (in control arm)45
- Urine sample35
- Atomoxetine35
- Bleomycin25
- Colonscopia55
- Melphalan35
- Encorafenib + Binimetinib25
- Interview45
- Pemetrexed/Cisplatin15
- Radical Prostatectomy15
- saliva sample25
- Smartwatch45
- Placebo capsule35
- Ritlecitinib15
- [177Lu]Lu-NeoB14
- [68Ga]Ga-NeoB14
- AAA61724
- Anvumetostat4
- Bosutinib24
- Omeprazolo34
- Bleximenib34
- Claseprubart24
- Efanesoctocog alfa24
- Plozasiran Injection4
- CGT948644
- AZD530514
- Itepekimab, Matched placebo for test product34
- Itepekimab (SAR440340)4
- Esami del sangue44
- SYT-51044
- LIBTAYO 350 mg concentrate for solution for infusion.14
- BHV-700024
- disitamab vedotin14
- AZD090124
- Pegylated liposomal doxorubicin (PLD)34
- Pelabresib34
- Finerenone (Kerendia, BAY94-8862)34
- Hydroxyurea34
- Ivosidenib44
- DOR/ISL4
- RCT21004
- LY353703144
- Bulevirtide14
- Idelalisib24
- Zasocitinib34
- Nirogacestat14
- Imlunestrant14
- Pacritinib34
- Paltusotine4
- Belrestotug4
- Budigalimab24
- Nemtabrutinib34
- Pembrolizumab (+) Berahyaluronidase alfa24
- Tepotinib24
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full deta4
- RO72042394
- Rucaparib14
- Saline Nasal Spray44
- Satralizumab24
- TAR-2004
- YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.34
- Venetoclax (VEN)34
- Sorafenib4
- Selpercatinib4
- BI 7645324
- MEDI47364
- XEN110134
- Belumosudil34
- BMS-98650444
- Chemotherapy drug44
- Cilta-cel4
- Daunorubicin34
- Caffeina34
- RPT90444
- Monalizumab14
- Bupropione34
- Sotagliflozin34
- Faricimab4
- Lurbinectedin14
- Povetacicept14
- Cabazitaxel24
- Efgartigimod IV24
- Ontunisertib44
- povorcitinib14
- Conduction system pacing44
- CTX00124
- dabrafenib24
- Icotrokinra14
- JNJ-7963532234
- Lucerastat24
- Pegylated liposomal doxorubicin34
- Placebo PH20 SC14
- Remdesivir44
- Treatment as Usual (TAU)34
- 68Ga-FAPI-464
- ALXN222014
- Fludeoxyglucose (18F)34
- Gemcitabine + carboplatin4
- JNJ-7893480424
- Placebo Supplement34
- Tozorakimab34
- Axicabtagene Ciloleucel14
- Ventilazione non invasiva34
- Vosoritide24
- Waiting List34
- Golexanolone4
- HYDROXYCHLOROQUINE34
- LUTATHERA24
- Biopsia della prostata14
- Degarelix14
- Ranibizumab24
- Rapcabtagene autoleucel4
- Tafasitamab4
- transthoracic echocardiography44
- visugromab (CTL-002)34
- Goserelin24
- Leucovorin Calcium4
- Cemdisiran24
- Optimal Medical Therapy24
- Pegaspargase14
- Psilocybin 25 mg44
- repetitive Transcranial Magnetic Stimulation (rTMS)44
- sertralina34
- T-DXd24
- Azitromicina34
- Escitalopram34
- Glucosio24
- Nilotinib14
- no interventions44
- Pazopanib4
- Quality of life44
- Sodium Chloride44
- Transcranial Direct Current Stimulation (tDCS)44
- [177Lu]Lu-DOTA-TATE14
- Adjuvant therapy4
- Aortic valve replacement34
- Biofeedback training44
- clozapine34
- Datopotamab deruxtecan (Dato-DXd)44
- ECG44
- Enoxaparin34
- Fianlimab4
- lung ultrasound44
- metilfenidato34
- mezigdomide34
- Proton Beam Therapy44
- Spirometria24
- Stereotactic Body Radiotherapy (SBRT)34
- Apremilast34
- Zolbetuximab24
- Blood collection34
- Bone Marrow Aspiration14
- Echocardiography Test24
- education34
- Electrical impedance tomography24
- Elettrocardiogramma34
- Garadacimab34
- givinostat34
- Ipilimumab/ Nivolumab4
- Mitapivat-matching placebo4
- Multigated Acquisition Scan14
- Ofatumumab24
- PF-0786848924
- Placebo (semaglutide)14
- Placebos44
- Sacituzumab Govitecan-hziy (SG)14
- Sham Comparator34
- Biopsia cutanea34
- Standard of care treatment34
- Tazemetostat14
- Sirolimus34
- Pozelimab24
- Forxiga 10 mg film-coated tablets24
- Rapamune 1 mg/mL oral solution34
- Vutrisiran23
- Radiprodil13
- Phesgo23
- Placebo matching Vicadrostat23
- Waitlist33
- Leniolisib3
- LP35213
- BGB-1141733
- Acalabrutinib (ACP-196)3
- CYB00323
- Trontinemab13
- Gazyvaro 1,000 mg concentrate for solution for infusion.3
- ALXN18503
- Probiotic33
- Mocertatug rezetecan33
- Axatilimab13
- Fenebrutinib3
Showing the top 600 of 1,000 matches — refine your search to narrow down.